Johnson & Johnson Cv Rx, Inc. Transaction History
Johnson & Johnson
- $475 Million
- Q1 2024
A detailed history of Johnson & Johnson transactions in Cv Rx, Inc. stock. As of the latest transaction made, Johnson & Johnson holds 4,103,430 shares of CVRX stock, worth $42.8 Million. This represents 15.74% of its overall portfolio holdings.
Number of Shares
4,103,430
Previous 3,495,575
17.39%
Holding current value
$42.8 Million
Previous $53 Million
40.92%
% of portfolio
15.74%
Previous 20.51%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
91Shares Held
13.8MCall Options Held
264KPut Options Held
89.3K-
Nea Management Company, LLC Timonium, MD2.37MShares$24.7 Million3.03% of portfolio
-
Black Rock Inc. New York, NY765KShares$7.98 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL619KShares$6.45 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA594KShares$6.2 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ589KShares$6.14 Million0.04% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $215M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...